According to MoonLake Immunotherapeutics's latest financial reports the company has $0.51 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.51 B | 608.6% |
2022-12-31 | $72.11 M | 797.08% |
2021-12-31 | $8.03 M |